Skip to main content
Drug bottle and Pill

Compare Eliquis vs. Brilinta

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Eliquis (apixaban) and Brilinta (ticagrelor) are both medications used to prevent blood clots, but they belong to different classes and work in distinct ways. Eliquis is a direct-acting oral anticoagulant (DOAC) that blocks factor Xa to prevent clots, while Brilinta is an antiplatelet medication that stops platelets from clumping together. Both medications are taken orally. Eliquis is FDA-approved for conditions like atrial fibrillation (AFib) and deep vein thrombosis (DVT), while Brilinta is used for other heart-related issues like acute coronary syndrome and stroke prevention. Eliquis is typically taken twice daily and is only available as a brand-name medication. Brilinta is also taken twice daily and does not have a generic version available. Common side effects of both medications include bleeding and bruising. Both medications can increase bleeding risk and have potential interactions that can also raise the risk of bleeding.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.